A comprehensive analysis of breast cancer microbiota and host gene expression
Open accessThe DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
The inflammatory tumoral-immune response alters the physiology of the tumor microenvironment, which may attenuate genomic instability. In addition to inducing inflammatory immune responses, several pathogenic bacteria produce genotoxins. However the extent of microbial contribution to the tumor microenvironment biology remains unknown. We utilized The Cancer Genome Atlas, (TCGA) breast cancer data to perform a novel experiment utilizing unmapped and mapped RNA sequencing read evidence to minimize laboratory costs and effort. Our objective was to characterize the microbiota and associate the microbiota with the tumor expression profiles, for 668 breast tumor tissues and 72 non-cancerous adjacent tissues. The prominent presence of Proteobacteria was increased in the tumor tissues and conversely Actinobacteria abundance increase in non-cancerous adjacent tissues. Further, geneset enrichment suggests Listeria spp to be associated with the expression profiles of genes involved with epithelial to mesenchymal transitions. Moreover, evidence suggests H. influenza may reside in the surrounding stromal material and was significantly associated with the proliferative pathways: G2M checkpoint, E2F transcription factors, and mitotic spindle assembly. In summary, further unraveling this complicated interplay should enable us to better diagnose and treat breast cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Intratumor bacteria have been reported in many tumor types (2-19)”
From The human tumor microbiome is composed of tumor type–specific intracellular bacteria (2020) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
vegan: Community Ecology Package
Oksanen, J., Simpson, G. L., Blanchet, F. G., Kindt, R., Legendre, P., Minchin, P. R., O'Hara, R. B., Solymos, P., Stevens, M. H. H., Szoecs, E., et al. (2001) · CRAN: Contributed Packages · doi:10.32614/cran.package.vegan · Cited by 22,615
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Silhouettes: A graphical aid to the interpretation and validation of cluster analysis
Rousseeuw, P. J. (1987) · Journal of Computational and Applied Mathematics · doi:10.1016/0377-0427(87)90125-7 · Cited by 21,392
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Cited by
Items 101–183 of 183
Interaction between the breast tumor microenvironment and gut microbiome
Tang, G., Millar, E. K. A., Graham, P., & Beretov, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2514136 · Cited by 15
“Diet has a modifiable role in shaping the composition of the gut microbiome, with most of this variation found to be in the ratio of Prevotella to Bacteriodes , both from the Bacteroidetes phylum.”
InfluentialThe Breast Microbiome in Breast Cancer Risk and Progression: A Narrative Review
Peters, B. A., Kelly, L., Wang, T., Loudig, O. D., & Rohan, T. E. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-0965 · Cited by 15
Lifestyle and Breast Cancer: Prevention and Treatment Support
Ratajczak, A. E., Jezierska, K., Szymczak‐Tomczak, A., Zawada, A. E., Rychter, A. M., Skoracka, K., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2025) · Cancers · doi:10.3390/cancers17172830 · Cited by 13
“The pathogenic relationship between the composition of the microbiota and breast cancer typically involves taxonomic changes occurring within the gut; however, this relationship is also supported by alterations observed in breast tumor tissue compared to healthy individuals [116].”
Qiu, J., Jiang, Y., Ye, N., Jin, G., Shi, H., & Qian, D. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05531-x · Cited by 15
“Thompson et al. found that certain bacteria including Listeria and Haemophilus infleunzae are linked to BC proliferation and epithelial-mesenchymal transformation (EMT) induction [41].”
BackgroundNandi, D., & Sharma, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1477980 · Cited by 13
Li, X., Yuan, X., Zhu, X., Li, C., Ji, L., Lv, K., Tian, G., Ning, K., & Yang, J. (2023) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001744 · Cited by 11
Actis, S., Cazzaniga, M., Bounous, V. E., D’Alonzo, M., Rosso, R., Accomasso, F., Minella, C., & Biglia, N. (2023) · Carcinogenesis · doi:10.1093/carcin/bgad071 · Cited by 11
Multiomics insights on the onset, progression, and metastatic evolution of breast cancer
Alvarez-Frutos, L., Barriuso, D., Duran, M., Infante, M., Kroemer, G., Palacios, R., & Senovilla, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1292046 · Cited by 12
“In cancer patients, there is an abundance of Thermus scotoductus , E. coli , Bacillus cereus , Shewanella , Corynbacterium (40), Bacillus , Staphylococcus , Enterobacteriaceae, Comamondaceae, Bacteroidetes (41), Mycobacterium fortuitum , and Mycobacterium phlei (42).”
BackgroundMicrobiome—Stealth Regulator of Breast Homeostasis and Cancer Metastasis
Furuta, S. (2024) · Cancers · doi:10.3390/cancers16173040 · Cited by 10
“…of Listeria fleischmannii ( Firmicutes ) in TN tumors is shown to be strongly associated with activation of the epithelial-to-mesenchymal transition (EMT) pathway, while the presence of Haemophilus influenza ( Pseudomonadota ) is correlated with tumor growth and cell cycle progression [87].”
BackgroundInsights into breast cancer phenotying through molecular omics approaches and therapy response
Belizário, J. E., & Loggulo, A. F. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2018.009 · Cited by 15
“influenza and Listeria spp inhabiting the stromal breast cancer tissue significantly influence the expression of genes in the proliferative pathways: G2M checkpoint, E2F TFs, and mitotic spindle assembly([68]).”
BackgroundThe Human OncoBiome Database: A Database of Cancer Microbiome Datasets
Nadia, N., & Ramana, J. (2019) · Current Bioinformatics · doi:10.2174/1574893614666190902152727 · Cited by 10
Rozani, S., & Lykoudis, P. M. (2024) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2024.115795 · Cited by 9
Bacteriophages: unlocking a new frontier in breast cancer management by defeating oncogenic bacteria
Ramadan, Y. N., Rashed, Z. I., Ahmed, R. F., Salem, H. A., Alshareef, H. M., Ahmed-Abakur, E. H., Alanazi, F. E., Elfadil, H., & Hetta, H. F. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00825-3 · Cited by 11
“Several microbiome species were reported to possess an estrobolome activity such as some genera in Proteobacteria family ( E. coli and Shigella ) [139] as well as Streptococcus pyogenes that were reported to boost estrogen levels in breast cancer [140].”
Tsai, C., Huang, W., Su, Y., Lee, F., Lee, C., Li, F.-Y., Yang, H., Lu, C.-Y., & Yang, P. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00810-2 · Cited by 12
Elucidating the roles of the mammary and gut microbiomes in breast cancer development
Hoskinson, C., Jiang, R., & Stiemsma, L. T. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1198259 · Cited by 13
“In a large cohort study, researchers integrated 16S rRNA sequencing with host tumor expression profiles in 668 breast tumor tissues and 72 noncancerous adjacent tissues (26).”
BackgroundInfluentialImplications of the microbiome and metabolic intermediaries produced by bacteria in breast cancer
D’Afonseca, V., Valdés-Muñoz, E., Leal, A. L., Suazo, P., & Parra-Cid, C. (2024) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2023-0316 · Cited by 9
“Currently, normal breast tissue hosts a dominant microbial community inclusive of Proteobacteria , Firmicutes (Urbaniak et al. , 2014), Sphingomonas yanoikuyae (Xuan et al. , 2014) , Actinobacteria (Thompson et al. , 2017) , Methylobacterium (Wang et al. , 2017) , Ralstonia (Constantini et al. , 2018) , Bacteroidaceae…”
BackgroundInfluentialTraps and trumps from adjacent-to-tumor samples in gastric cancer research
de Assump玢o, P. P., Khayat, A., Ara鷍o, T. M. T., Barra, W. F., Ishak, G., Ramos, A. M. P. C., dos Santos, S. E. B., dos Santos, 耼. K. C. R., Demachki, S., de Assump玢o, P. B., et al. (2018) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2018.05.10 · Cited by 8
The Anti- and Pro-Tumorigenic Role of Microbiota and Its Role in Anticancer Therapeutic Strategies
Greco, G., Zeppa, S. D., Agostini, D., Attisani, G., Stefanelli, C., Ferrini, F., Sestili, P., & Fimognari, C. (2022) · Cancers · doi:10.3390/cancers15010190 · Cited by 9
Kibria, M. K., Ali, M. A., & Mollah, M. N. H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0312493 · Cited by 7
D’Angelo, A., Zenoniani, A., Masci, M., Aceto, G. M., Piattelli, A., & Curia, M. C. (2025) · Microorganisms · doi:10.3390/microorganisms13091995 · Cited by 8
“The presence of Proteobacteri a in tumor tissue samples increased, while Actinobacteria was also observed in non-cancerous adjacent tissue samples [131].”
Canzian, J., Jacobs, F., Floreani, A., Miggiano, C., Tiberio, P., Pozzi, C., Santoro, A., Zambelli, A., Rescigno, M., & Sanctis, R. D. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105035 · Cited by 8
Vahid, F., Hajizadeghan, K., & Khodabakhshi, A. (2023) · Biomedicines · doi:10.3390/biomedicines11071845 · Cited by 10
“Several studies have shown that certain types of gut bacteria can affect the metabolism of dietary components, such as phytoestrogens, which are plant-derived compounds that can have either protective or harmful effects on breast cancer, depending on their concentration and form [75,76].”
BackgroundWang, X., Li, J., Shi, W., Huang, Z., Xia, W., Huang, J., Su, Y., Wang, S., Shi, Y., Bi, X., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2020-0364 · Cited by 7
“A variety of bacteria have been found in greater abundances in the breast cancer tissue compared with paired normal tissue, including Methylobacterium [2], Atopobium, Fusobacterium, Gluconacetobacter, Hydrogenophaga, Lactobacillus [3], Bacillus, Enterobacteriaceae, Staphylococcus [1], Haemophilus influenzae, and Strep…”
BackgroundMicrobiome dynamics in breast cancer: Mechanisms, therapeutic impacts and research gaps
Effiong, M. E., Ikeji, N. C., Bella-Omunagbe, M., Afolabi, I. S., & Chinedu, S. N. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104879 · Cited by 8
Maternal obesity and resistance to breast cancer treatments among offspring: Link to gut dysbiosis
Andrade, F. D. O., Verma, V., & Hilakivi-Clarke, L. A. (2022) · Cancer Reports · doi:10.1002/cnr2.1752 · Cited by 6
“Studies that have investigated if the microbiota is linked to breast cancer risk show a difference in the composition of the breast microbiota in normal breast tissue between healthy women and women with breast cancer,(93) between breast cancer and breast tissue with benign growth,(94) or between breast cancer and nor…”
BackgroundNaik, A., & Godbole, M. S. (2024) · Cancer Reports · doi:10.1002/cnr2.70005 · Cited by 9
Role of human microbiota in facilitating the metastatic journey of cancer cells
Shah, H., Patel, P., Nath, A., Shah, U., & Sarkar, R. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03957-8 · Cited by 5
“Staphylococcus (Firmicutes) and Corynebacterium (Actinobacteria) are widespread in wet places, but Cuti-bacterium (Actinobacteria) flourishes in moist environments with less variety (Carmona-Cruz et al. 2022).”
InfluentialBreast Cancer and Its Relationship With the Microbiota
(2019) · Case Medical Research · doi:10.31525/ct1-nct03885648 · Cited by 5
Impact of gut permeability on the breast microbiome using a non-human primate model
Bawaneh, A., Shively, C. A., Tooze, J. A., & Cook, K. L. (2022) · Gut Microbiome · doi:10.1017/gmb.2022.9 · Cited by 6
“…and breast tumour-specific microbiomes to exist (Banerjee et al., 2018; Chiba et al., 2020; Hieken et al., 2016; Nejman et al., 2020; Parida and Sharma, 2020; Plaza-Diaz et al., 2019; Shively et al., 2018; Soto-Pantoja et al., 2021; Thompson et al., 2017; Tzeng et al., 2021; Urbaniak et al., 2014).”
Proteomics Investigation of the Impact of the Enterococcus faecalis Secretome on MCF-7 Tumor Cells
Alwehaibi, M. A., Al‐Ansari, M. M., Alfadda, A. A., AlMalki, R. H., Masood, A., Rahman, A. M. A., & Benabdelkamel, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914937 · Cited by 5
“Changes in a distinct microbiome may contribute to the development of cancer and affect tumor growth [10–14].”
BackgroundAssociation of Microbes with Breast Cancer
Noguti, J., & Lee, D. J. (2019) · Current cancer research · doi:10.1007/978-3-030-04155-7_7 · Cited by 5
The role of gut microbiota in breast cancer: biomarker identification and therapeutic applications
Abrishami, M., Sabouri, M., Joneidi, F., Haghshenas, Z., Khalili‐Tanha, G., & Nazari, E. (2025) · Antonie van Leeuwenhoek · doi:10.1007/s10482-025-02217-2 · Cited by 4
“This reduction is also associated with inflammatory markers and altered immune cell activity increasement (Francescone et al. 2014; Thompson et al. 2017; Tzeng et al. 2021; Viswana-than et al. 2023).”
Zhou, Y., Jiang, M., Li, X., Shen, K., Zong, H., Lv, Q., & Shen, B. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1490007 · Cited by 4
Arvelo, F. A., Sojo, F. J., & Cotte, C. (2021) · Investigación Clínica · doi:10.22209/ic.v62n4a09 · Cited by 5
Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors
Silva-Pilipich, N., Covo-Vergara, Á., & Smerdou, C. (2023) · Cancers · doi:10.3390/cancers15082352 · Cited by 5
Wu, Y., Zhang, Y., Zhang, W., Huang, Y., Lu, X., Shang, L., Zhou, Z., Chen, X., Li, S., Cheng, S., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05014-4 · Cited by 4
Valsecchi, A. A., Ferrari, G., Paratore, C., Dionisio, R., Vignani, F., Sperone, P., Vellani, G., Novello, S., & Maïo, M. D. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104328 · Cited by 4
Gaber, M. K., Moulden, L. M., Wilson, A. S., Payne, V. S., Holmes, J., Neary, K., Peoples, A. E., Duet, M. L., Katz, A. J., Vidi, P., et al. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101284 · Cited by 3
“This enrichment was also observed in breast tumors relative to the normal adjacent tissues [19,20].”
Maranha, A., Alarico, S., Nunes‐Costa, D., Melo-Marques, I., Roxo, I. C., Castanheira, P., Caramelo, O. L., & Empadinhas, N. (2024) · Microorganisms · doi:10.3390/microorganisms12071425 · Cited by 4
“An increase in the abundance of M. fortuitum and M. phlei , both opportunistic pathogens, was observed in breast cancer tissue compared to adjacent normal tissue [165].”
BackgroundMammary Gland Microbiota in Benign Breast Diseases
Ukraincev, N. I., Kashutina, M. I., Касаткина, Л. И., Бахтиерович, А. А., & Zhernov, Y. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209951 · Cited by 2
Vicente-Valor, J., Aguado, C., Mateos, M., Tesolato, S. E., Antoñanzas, M., Paz-Cabezas, M., Gómez‐Garré, D., Ortega‐Hernández, A., Bernabé, M. J., Morales, B., et al. (2026) · Lung Cancer · doi:10.1016/j.lungcan.2026.109381 · Cited by 4
The human microbiome reshapes the breast cancer immune-metabolic-hormonal microenvironment
Wang, Q., 张富荣, Xin, Y., Yang, R., Tang, Z., Wu, Z., & Ming, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1774211 · Cited by 2
Bacterial Darth Vader: May the force be with you
Polyák, K. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.05.008 · Cited by 3
Microbiome, immune system and cancer: three sides of the one medal
Belyavskaya, V. A., Чердынцева, Н. В., Kzhyshkowska, J. G., & Litvyakov, N. V. (2023) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2022-21-6-131-144 · Cited by 5
[Sarcopenia: definition and clinical implications].
Kostka, T. (1999) · PubMed · Cited by 3
Duan, Y., Ma, F., Guo, B., Chen, Z., Liu, Y., Jiang, X., Rong, Z., Zou, Y., Zhang, H., Wang, T., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2783293/v1 · Cited by 2
Li, H., Leaman, A. A., & Zheng, Q. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.04.001 · Cited by 4
Race-related host and microbe transcriptomic signatures in triple-negative breast cancer
Kumar, R., Duyar‐Ayerdi, S., Sundaresan, A., Srinivasasainagendra, V., Pedamallu, C. S., Behring, M. P., Chandrashekar, D. S., Eltoum, I.-E. A., Varambally, S., Tiwari, H. K., et al. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00806-y · Cited by 1
Nawaz, Y., Munir, S., Aslam, S., Butt, F. R., Tanvir, F., Nawaz, B., Bashir, K., & Tahreem, R. (2025) · Current Genomics · doi:10.2174/0113892029371937250918105052 · Cited by 3
“It is important to note that these findings may be influenced by the ethno-specific characteristics of the study population [54, 55].”
Wei, W. W., Zhang, X., Ma, X., Meng, R., Liu, Y., Zhu, J., Yu, Z., Wu, Z., Ni, Y., Li, X., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158284 · Cited by 1
Al‐Ansari, M. M., Mahmood, S. M., & Al-Alwan, M. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27114723 · Cited by 2
“Thompson et al. [38] established a link between breast cancer and dysbiosis, as evidenced by increased levels of pro-inflammatory bacteria, including Staphylococcus and Enterobacteriaceae, in tumor tissues.”
InfluentialCancer and Immunology – The Homeostasis Dance
Ekine-Afolabi, B. A. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_3-1 · Cited by 1
Chow, L., Flaherty, E., Pezzanite, L. M., Williams, M., DOW, S. W., & Wotman, K. L. (2024) · Veterinary Sciences · doi:10.3390/vetsci11040167 · Cited by 1
“…of alterations in cellular and molecular biology have advanced earlier cancer diagnosis and treatment in horses, microbial contributions to tumor growth and host differential gene expression and the potential therapeutic implications of such characterization remain incompletely unexplored [45].”
BackgroundZenati, F. A., Baldi, S., Gloria, L. D., Djoudi, F., Bertorello, S., Ramazzotti, M., Niccolai, E., & Amedei, A. (2025) · Genes · doi:10.3390/genes16070806 · Cited by 1
“Similarly, in a recent study of Italian BC patients, no significant differences were observed between tumor and non-pathological adjacent tissues in terms of microbial community structure or bacterial taxa composition [10].”
Hive Panel Explorer: an interactive network visualization tool
Perez, S. E. I., Hahn, A. S., Krzywinski, M. I., & Hallam, S. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa683 · Cited by 1
Clinical Connections Between the Microbiota and Breast Cancer (Onset, Progression and Management)
Filippone, A., & Magno, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00099-1 · Cited by 1
The Important Role of Breast Microbiota in Breast CancerPreprint
Su, K.-Y., Lee, W.-L., & Balasubramaniam, V. R. M. T. (2020) · Preprints.org · doi:10.20944/preprints202010.0437.v1
An atlas of bacterial and viral associations in cancerPreprint
Borchmann, S. (2019) · bioRxiv · doi:10.1101/773200 · Cited by 2
Microbiome and breast cancer: A systematic review and meta-analysisPreprint
Thu, M. S., Chotirosniramit, K., Nopsopon, T., Hirankarn, N., & Pongpirul, K. (2022) · medRxiv · doi:10.1101/2022.12.30.22284053 · Cited by 1
“Thompson 2017 Case-control USA 740 (51)”
The Key Role of Human Microbiota in Breast CancerPreprint
Filippone, A., Rossi, C., Rossi, M. M., Guarino, D., Maggiore, C., Micco, A. D., Ticca, L., Palma, S. D., Bolognino, R., Sánchez, A. M., et al. (2021) · Preprints.org · doi:10.20944/preprints202102.0393.v1
Aarnoutse, R. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20211203ra
Case presentation: full mouth implant treatment via a trio of modalities.
Shapiro, S. A. (2011) · PubMed · Cited by 1
(2021) · Elsevier eBooks · doi:10.1016/b978-0-323-68013-4.00080-8
Research Progress of Microbiome in Breast Cancer
蘧, 曼. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.123224
Data from Diet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Soto‐Pantoja, D. R., Gaber, M. M., Arnone, A. A., Bronson, S. M., Cruz‐Diaz, N., Wilson, A. S., Clear, K. Y. J., Ramirez, M. U., Kucera, G. L., Levine, E. A., et al. (2023) · doi:10.1158/0008-5472.c.6513187.v1
Annisa, A., Putri, R. G. P., & Solikhah, S. (2023) · Indonesian Journal of Cancer · doi:10.33371/ijoc.v17i4.1030
“) [11] 16S rRNA sequencing HER2+, ER+, triple negative - Cancerous breast tissue Proteobacteria (48%), Actinobacteria (26.3%), Firmicutes (16.2”
BackgroundInfluentialOrchestration of the dynamic molecular and cellular society in cancer by intratumoral bacteria
Zhong, R., Yu, X., Yang, F., Yao, X., & Liu, X. (2023) · JUSTC · doi:10.52396/justc-2022-0186
Microbes and Cancer: Exploring the Interplay Between Pathogens and Tumorigenesis
Elwakil, B. H., & El‐Naggar, M. Y. (2024) · Springer eBooks · doi:10.1007/978-3-030-80962-1_382-1 · Cited by 1
Research Progress of Gut Microbiota in Immunity and Breast Cancer
任, 俊. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153603
Microbes and Cancer: Exploring the Interplay Between Pathogens and Tumorigenesis
Elwakil, B. H., & El‐Naggar, M. Y. (2025) · Springer eBooks · doi:10.1007/978-3-032-00761-2_382
Devoy, C., Devoy, C., McLaughlin, R. A., Cronin, C., Clarke, R., Connolly, R. M., Crowley, E., Raigal‐Aran, L., Collins, D., Bird, B., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07074-1 · Cited by 1
“The psychological burden of a cancer diagnosis and discomfort with stool sampling may have deterred some from consenting [19] and participation was likely influenced by a combination of altruistic motives and perceived burden [20].”
Chen, L., Zhang, Y., Wang, Y., Cao, D., Tai, J., & Gao, K. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1724429
Therapeutic potential of the intratumoral microbiota in tumors
Mahmoudy, H., Guemih, I., & Ennaji, M. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30225-1.00039-7
The Role of the Microbiome in Cancer Development
Wang, Y., Shi, Y., Duan, J., Tang, H., Liu, S., & Yang, J. (2026) · Cancer Biome and Targeted Therapy · doi:10.66505/cbtt.v1i1.19
Miyake, T., Kojima, M., Tani, S., Muramoto, K., Maehira, H., Kaida, S., Shimizu, T., & Tani, M. (2026) · International Journal of Colorectal Disease · doi:10.1007/s00384-026-05154-2
“In our cohort, we found that Proteo-bacteria were significantly enriched in right-sided tumors with lymph node metastasis, consistent with prior reports of Proteobacteria dominance in colorectal and even breast cancer tissues [16, 20, 21].”
Leng, F., 夏瑞瑛, Pei, J., Shi, Y., Gao, C., Wang, F., & Li, Y. N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1840903
Mohammadizade, A. (2026) · Journal of Current Biomedical Reports · doi:10.66224/jcbior.7.1.347
“They also reported that the amount of Streptococcus pyogenes increases in tumor tissue, which is a bacterium associated with increased systemic estrogen via β-glucuronidase activity, and it increases the risk of breast cancer [38].”
Narasimhamurthy, R. K., N, R. K., Rajendra, V. K., & Shetty, P. (2026) · Translational research · doi:10.1016/j.trsl.2026.09.007
Intratumoral Microbiota in Fueling Cancer and Steering Treatment Response
Xu, M., Yu, J., Chen, Y., Ge, S., Ye, L., Wang, Y., 周一雄, & Jia, R. (2026) · MedComm · doi:10.1002/mco2.71052
“V3 –V5 region sequencing has previously been reported to perform best for breast tissue [ 49 ].”
Cossu, C., Adamo, M., Lorenzo, A. D., & Conti, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1944056
“However, both studies were based predominantly on computational analysis of sequencing-derived microbial reads and therefore establish correlations rather than direct causal relationships (55, 56).”
Intratumoral Microbiome–Tumor Microenvironment Crosstalk in Breast Cancer Aggressiveness
Mushii, O., Lukianova, Y., & Bazas, V. (2026) · The Breast Journal · doi:10.1155/tbj/1508684
“Analysis of 668 BC tissue samples from The Cancer Genome Atlas revealed correlations between microbiome composition and gene expression profles in tumor cells, with Listeria feischmannii infltration associated with altered expression of EMT-related genes [13].”
Metadata
- Authors
- Thompson, K. J., Ingle, J. N., Tang, X., Chia, N., Jeraldo, P. R., Walther-Antonio, M. R., Kandimalla, K. K., Johnson, S., Yao, J. Z., Harrington, S. C., Suman, V. J., Wang, L., Weinshilboum, R. L., Boughey, J. C., Kocher, J.-P., Nelson, H., Goetz, M. P., & Kalari, K. R.
- Affiliations
- Mayo Clinic (US)
- University of Minnesota (US)
- Corresponding author
- Kalari, Krishna R.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-11-30
- Volume
- 12
- Issue
- 11
- Pages
- e0188873
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5708741
- OpenAlex
- W2771514310
- Cited by
- 183
- References
- 63
- Citations by year
- 2026: 13 · 2025: 23 · 2024: 24 · 2023: 35 · 2022: 23 · 2021: 26 · 2020: 18 · 2019: 12 · 2018: 7
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Mayo Clinic (P50 CA116201)
- National Institutes of Health
- Center for Individualized Medicine, Mayo Clinic (P50CA116201)
- National Cancer Institute (P50CA116201)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, tumor microbiome, tumor microenvironment, host gene expression, Proteobacteria, actinobacteria, Listeria, epithelial-mesenchymal transition, Haemophilus influenzae, G2/M checkpoint, E2F transcription factors, mitotic spindle assembly, tumor-associated bacteria
- MeSH terms
- Breast Neoplasms, Female, Humans, RNA, Ribosomal, 16S, Gene Expression, Sequence Analysis, RNA, Proteobacteria, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.